Study to Evaluate Adverse Events and Change in Disease Activity With Oral Tablets of Upadacitinib in Adult Participants With Non-Segmental Vitiligo
Clinical trial NCT04927975 · COMPLETED
Trial details
- NCT number
- NCT04927975
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-30
- Primary completion
- 2023-01-13
- Enrollment
- 185
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.